Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Diabetic foot problems: prevention and management

NICE guideline
Reference number: NG19
Published: 26 August 2015
Last updated: 11 October 2019

History

Guidance published

Consultation comments and responses (PDF 770 KB)

Published:

18 January 2023
Equality impact assessment - final (PDF 188 KB)

Published:

18 January 2023
Committee member list (PDF 128 KB)

Published:

18 January 2023

Stakeholder list updated

Stakeholder list (PDF 158 KB)

Published:

17 January 2023

Declaration of interests

Register of interests (PDF 776 KB)

Published:

17 January 2023

Draft guidance consultation

Draft guidance consultation
Draft guideline (PDF 279 KB)

Published:

29 September 2022
Evidence review (PDF 2.28 MB)

Published:

29 September 2022
Comments form (MSWord 41 KB)

Published:

29 September 2022

Committee meetings

Committee meeting
Minutes 16 - Diabetic foot (PDF 203 KB)

Published:

25 July 2022
Minutes 19 - Diabetic foot (PDF 210 KB)

Published:

21 November 2022

Scope published

Final scope (PDF 165 KB)

Published:

12 May 2022

Update on 11 October 2019

Committee list updated
Committee member list (PDF 180 KB)

Published:

20 July 2021
Stakeholder list updated
Stakeholder list (PDF 128 KB)

Published:

02 July 2019
Stakeholder list (PDF 135 KB)

Published:

10 October 2019
Guidance published
Equality impact assessment (PDF 194 KB)

Published:

11 October 2019
Consultation comments and responses (PDF 453 KB)

Published:

11 October 2019
Declaration of interests
Register of interests (PDF 546 KB)

Published:

11 October 2019
Draft guidance consultation
Draft guidance consultation
Evidence review (PDF 2.32 MB)

Published:

16 April 2019
Draft guideline (PDF 474 KB)

Published:

16 April 2019
Equality impact assessment (PDF 194 KB)

Published:

16 April 2019
Summary paper Visual summary (PDF 178 KB)

Published:

16 April 2019
Comments form (MSWord 68 KB)

Published:

23 April 2019
Scope published
Final scope (PDF 363 KB)

Published:

21 March 2019
Committee meeting: 1 (Managing common infections meeting 22)
Minutes (PDF 315 KB)

Published:

20 March 2019

Original development on 26 August 2015

Stakeholder list updated
Stakeholder list (PDF 128 KB)

Published:

02 July 2019
Surveillance consultation
Surveillance consultation
Comments form (MSWord 29 KB)

Published:

25 April 2019
Surveillance review proposal (PDF 1.01 MB)

Published:

25 April 2019
Committee meeting
Minutes 1 (2019 update) (PDF 315 KB)

Published:

31 January 2019
Minutes 2 (2019 update) (PDF 165 KB)

Published:

18 June 2019
Equality impact assessment
Equality impact assessment (PDF 104 KB)

Published:

26 August 2015
Final committee member list
Final committee member list (PDF 164 KB)

Published:

26 August 2015
Stakeholder comments table
Stakeholder comments table (PDF 1.03 MB)

Published:

26 August 2015
Equality impact assessment (recommendations)
Equality impact assessment (recommendations) (PDF 396 KB)

Published:

22 July 2015
Guideline consultation
Guideline consultation information
Draft guideline (PDF 1.79 MB)

Published:

07 January 2015
Draft NICE guideline (PDF 302 KB)

Published:

07 January 2015
Draft guideline appendices
Appendices A-F (PDF 3.52 MB)

Published:

07 January 2015
Appendix G (PDF 2.96 MB)

Published:

07 January 2015
Appendices H-K (PDF 3.77 MB)

Published:

07 January 2015
Health economic plan
Health economic plan
Health economic plan (PDF 17 KB)

Published:

08 December 2014
Review questions (PDF 93 KB)

Published:

08 December 2014
Search strategies (PDF 51 KB)

Published:

08 December 2014
List of registered stakeholders
List of registered stakeholders (PDF 52 KB)

Published:

09 June 2015
Equality impact assessment - scoping
Equality impact assessment - scoping (PDF 223 KB)

Published:

12 August 2013
Guideline development and consultation
Guideline development and consultation
GDG minutes
GDG 9 minutes (PDF 132 KB)

Published:

30 October 2014
GDG 8 minutes (PDF 130 KB)

Published:

17 September 2014
GDG 7 minutes (PDF 126 KB)

Published:

06 August 2014
GDG 6 minutes (PDF 125 KB)

Published:

24 June 2014
GDG 5 minutes (PDF 125 KB)

Published:

27 May 2014
GDG 4 minutes (PDF 126 KB)

Published:

02 April 2014
GDG 3 minutes (PDF 125 KB)

Published:

09 December 2013
GDG 2 minutes (PDF 125 KB)

Published:

12 November 2013
GDG 1 minutes (PDF 131 KB)

Published:

09 September 2013
Guideline Development Group members (GDG) (PDF 163 KB)

Published:

07 January 2014
Diabetic footcare (update): scoping workshop, consultation and final scope
Diabetic footcare (update): scoping workshop, consultation and final scope
Diabetic footcare (update): scope consultation information
Diabetic footcare (update): draft scope (PDF 184 KB)

Published:

17 April 2013
Stakeholder comments table (PDF 293 KB)

Published:

31 July 2013
Final scope (PDF 188 KB)

Published:

31 July 2013